Brief: Medovex receives approval from Australia's TGA for its Denervex system
29/08/2017 14:10
Aug 29 (Reuters) - Medovex Corp MDVX.O
* Medovex Corporation receives regulatory approval from
Australia's Therapeutic Goods Administration (TGA) for its
Denervex system
Source text for Eikon: ID:nMKW5r9sja
Further company coverage: MDVX.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Innoveren Scientific
See all newsBrief: H-Cyte Announces Intent To Acquire Skindisc
Brief: Medovex Corp Announces Name Change To H-Cyte And New Ticker Symbol
Brief: Nasdaq Announces Delisting Of Certain Securities
Brief: Medovex files for non-timely 10-Q
Brief: Medovex Corp announced that it has launched its DenerveX System device in Spain with distributor Prim SA